Kasturi Malaviya, DO
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 4
- Since medical school
- 9 years
- University of New England, College of Osteo Medicine, 2017
Offices
4 locations · County of Santa Clara · 1,000 clinicians in this group
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Malaviya’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Medicaid work
$163,875 in 2024
Medicaid paid $163,875 for 1,803 billed services this clinician did in 2024, up to 61 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 287 | $163,788 |
| Short return visit | 401 | $87 |
| Pain severity quantified; pain present (COA) (ONC) | 60 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 23 | $0 |
| Medication list documented in medical record (COA) | 308 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 205 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 90 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 74 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 204 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 137 | $0 |
| Short return visit (20+ min) | 14 | $0 |
| 2024 | 1,803 | 11 | 61 | $163,875 |
| 2023 | 1,014 | 9 | 75 | $184,656 |
| 2022 | 886 | 10 | 59 | $90,123 |
| 2021 | 2,580 | 16 | 95 | $343,319 |
| 2020 | 458 | 3 | 105 | $67,126 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 348 | $184,602 |
| Short return visit | 379 | $54 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 16 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 84 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 18 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 78 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 41 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 16 | $0 |
| Short return visit (20+ min) | 34 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 288 | $89,550 |
| Return visit (30+ min) | 293 | $517 |
| Short return visit | 63 | $56 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 13 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 72 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 12 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 17 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 46 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 18 | $0 |
| Short return visit (20+ min) | 64 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 785 | $336,502 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 60 | $2,400 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 57 | $2,280 |
| Short return visit | 578 | $728 |
| Return visit (30+ min) | 227 | $697 |
| Short return visit (20+ min) | 413 | $670 |
| ELECTROLYTE PANEL | 12 | $15 |
| Creatinine; blood | 12 | $11 |
| Urea nitrogen; quantitative | 12 | $8 |
| Blood glucose (sugar) level | 12 | $8 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 75 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 101 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 202 | $67,018 |
| Short return visit | 205 | $109 |
| Short return visit (20+ min) | 51 | $0 |
Drugs they prescribed that Part D paid
$12,067
Pharmacies billed $12,067 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (13 of 194) in 2024. A higher opioid share than 9 in 10 peers; the typical internal medicine clinician is at 1%.
155 generic and fewer than 11 brand-name prescriptions · $12,067 in drug cost · 22 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 11 | $350 | $32 |
Year by year
| 2024 | 194 | 83 | 7% (13) | None | $12,067 |
| 2023 | 122 | 49 | None | None | $8,000 |
| 2022 | 192 | 56 | 7% (14) | 21% | $19,256 |
| 2021 | 445 | 135 | None | None | $23,516 |
| 2020 | 84 | 31 | None | None | $1,617 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 3 drugs
| Buprenorphine-Naloxone | 11 | $2,370 | $215 |
| Atorvastatin | 13 | $133 | $10 |
| Amlodipine Besylate | 12 | $42 | $3 |
2021: 15 drugs
| Diclofenac | 16 | $240 | $15 |
| Pantoprazole | 16 | $237 | $15 |
| Atorvastatin | 30 | $237 | $8 |
| Hydralazine | 13 | $140 | $11 |
| Fluticasone Propionate | 12 | $104 | $9 |
| Metformin | 18 | $104 | $6 |
| Furosemide | 14 | $103 | $7 |
| Atenolol | 13 | $95 | $7 |
| Metoprolol | 13 | $93 | $7 |
| Simvastatin | 13 | $87 | $7 |
| Hydrochlorothiazide | 13 | $86 | $7 |
| Naproxen | 16 | $71 | $4 |
| Gabapentin | 13 | $62 | $5 |
| Omeprazole | 11 | $55 | $5 |
| Amlodipine Besylate | 12 | $53 | $4 |
Professional record
- NPI
- 1912415209
- Trained
- University of New England, College of Osteo Medicine, 2017 · 9 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 510 Capitol Village Cir, San Jose, CA, 95136
- NPI first listed
- 2018-01-20
- NPI last updated
- 2025-03-27
- NPI record certified
- 2025-03-27
This is when the NPI record was last certified, not a medical board exam.